Glossary
Renal Risk
Updated February 28, 2026
Renal risk reflects how kidney function affects supplement safety, especially for high burden compounds.
Why it matters
Kidney capacity influences how fluid load, mineral clearance, and protein-heavy protocols are tolerated.
CKD-stage-aware caution
For reduced kidney function, recommendations may be more conservative or paused depending on severity.
Avoid broad stack scaling and prioritize clinician coordination.
Hydration and lab triggers
- rising creatinine trend, edema, reduced urine output, or unexplained fatigue should trigger stop-and-review
- hydration consistency is a required context variable before dose increases
- monitor electrolyte shifts when combining protein-heavy and mineral-heavy stacks
High-caution compounds
- high-dose creatine in severe CKD contexts
- aggressive mineral clustering
- protein-dense stacked protocols without renal context
Practical action step
Before increasing dose, log hydration and current kidney-related lab context for 3–5 days and review with clinician support.
Uncertainty and limits
- Evidence is limited on safe upper boundaries for many compounds in moderate-to-advanced CKD.
- Evidence is limited on long-term kidney-safe timing strategies in non-prescription stacks.
Cross-site references
How this appears in Unfair
Unfair increases caution for renal-risk profiles by suppressing escalation and emphasizing lower complexity plans.
Clinical safety note
If renal warning signs appear, pause relevant stacks and get clinical evaluation before resuming.